\
&
Contact us
This was 10 months ago
LocationOnline
ProgrammesThe European Partnership for Personalised Medicine has just launched a new opportunity for start-ups, researchers and early-stage teams working on cutting-edge solutions in personalised medicine.
Translating breakthrough innovations in personalised medicine (PM) into commercialised solutions that directly benefit patients remains a critical challenge in the healthcare industry. The absence of tailored business support often hinders the translation of scientific advancements & discoveries into market-ready solutions.
The EP PerMed Venture Creation Programme offers guidance from experienced mentors, ensuring that each project receives support throughout its journey. In this webinar, EP PerMed will provide an overview of the programme, including its requirements, the application process, and the support available, offering key insights for those interested in applying.
More information and registration here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Digital, Industry & Space Digital Europe
If you’ve never heard of Limecraft, you’re clearly not working in the media sector. Their SaaS platform provides integrated workflows for media management, scripted and unscripted TV, and subtitling and localisation. It is used by leading broadcasting companies – such as BBC, VRT, NPO… – and production firms of which De Mensen or Hotel Hungaria might ring a bell (at least if you are Belgian).
NCP Flanders went to Ghent to interview Maarten Verwaest, CEO and cofounder, about how he sees Horizon 2020. Limecraft is a partner in the MeMAD project, which is a collaborative RIA project submitted to an ICT call topic.